June 5, 2025
Deal Summary
On May 28, the share transfer agreement was signed for all the shares of Sakura Pharmacy Group.
Acquired shares
NSSK-WW Co., Ltd.
(100% shares)
Figure of Capital Relationship
Shareholders
Contract date
May 28, 2025
Share transfer date
August, 2025 (scheduled)
Acquired group
Sakura Pharmacy Group
Number of shares
acquired
19,000,000,001 shares
(100% ownership)
100%
Scope of target of transfer (Sakura Pharmacy Group)
Holding company NSSK-WW Co., Ltd.
100%
Holding company NSSK-W Co., Ltd.
100%
KRAFT Inc.
Headquarters functions, Dispensing pharmacy business
100%
Acquisition price
¥59,100 million
Financing plan
Borrowings from our Bank primarily
SAKURA PHARMACY Inc.
Dispensing pharmacy business
Pharmacy subsidiaries
Dispensing pharmacy business
Other subsidiaries
Store real estate management, Manufacturing and sales of
generic drugs
Positioning of This Initiative within the Medium- and Long-term Vision
This initiative is expected to enable us to achieve the target net sales of ¥700 billion for FY4/30, as outlined in the medium- and long-term vision "Ambitious Goals 2034", ahead of schedule.
Net Sales
（¥ billion） 1,000
AIN
Group
Sakura Pharmacy Group
Total
(simple sum)
Ambitious Goals 2034
800
Net sales ¥456.8 billion ¥153.6 billion ¥610.4 billion
700+α
600
Number of pharmacies
1,290 833 2,123
610.4
This initiative
400
200
170.2 187.9
125.5 129.4 142.8 154.6
234.8 248.1
268.4 275.6
292.6 297.3 316.2
358.7
399.8
0
4/10 4/11 4/12 4/13 4/14 4/15 4/16 4/17 4/18 4/19 4/20 4/21 4/22 4/23 4/24 4/25 4/26 4/27 4/28 4/29 4/30
(FY)
The total sales of the AIN Group (FY4/25) and the Sakura Pharmacy Group (FY3/24) is a simple sum The financial results of the Sakura Pharmacy Group for FY3/25 are currently undetermined
We are currently assessing the impact of this initiative on full-year financial results for FY4/26. We will inform you as soon as the details are known
Purpose of This Initiative
This initiative will significantly contribute to the "Top-line expansion," which is the dispensing pharmacy business strategy outlined in the Medium- and Long-term Vision "Ambitious Goals 2034."
Chubu
353
Tohoku
196
Kansai
296
Kanto
816
Chugoku/ Shikoku
175
Top-line Expansion by Increasing the Number of Pharmacies
Hokkaido
151
AIN Group | 1,290 | stores |
Sakura Pharmacy Group | 833 | stores |
Total | 2,123 | stores |
Kyushu/ Okinawa
136
The number of pharmacies in the AIN Group
Market Position after This Initiative
With the acquisition of the Sakura Pharmacy Group, our total sales of dispensing pharmacy business will exceed ¥500 billion, establishing us as the overwhelming leader in dispensing pharmacy industry in Japan.
AIN Group＋Sakura Pharmacy Group
AIN Group
384.8
538.4
Nihon Chouzai
Sugi Holdings
Welcia Holdings
SUGI Holdings
Company A Company B Company C
Qol Holdings
MatsukiyoCocokara & Co.
Company D Company E
Sakura Pharmacy Group
Tsuruha Holdings
TSURUHA HOLDINGS
Medical System Network
Company F Company G
171.6
162.5
153.6
126.0
117.0
218.7
282.5
322.0
Sales of dispensing pharmacy business to exceed ¥500 billion0 100 200 300 400 500 600
Based on latest disclosure materials
Sales of dispensing pharmacy business
（¥ billion）
The total sales of the AIN Group (FY4/25) and the Sakura Pharmacy Group (FY3/24) is a simple sum
Financial Statements
The Sakura Pharmacy Group is scheduled to join us in August. The total net sales of the AIN Group and the Sakura Pharmacy Group would amount to approximately ¥600 billion, when simply summed. We are currently assessing the impact of this initiative on full-year financial results for FY4/26.
(¥ billion) | FY4/25 results | FY3/24 results | ||
Net sales | 456.8 | 153.6 | ||
Operating income | 16.8 | 12.7 | ||
% of net sales | 3.7 | 8.3 | ||
Ordinary profit | 18.0 | 6.8 | ||
% of net sales | 3.9 | 4.4 | ||
Net income | 9.2 | 3.6 | ||
% of net sales | 2.0 | 2.3 |
Based on disclosure materials
The AIN Group's figures are actual results for FY4/25, and the Sakura Pharmacy Group's figures are actual results for FY3/24
Inquiries related to this presentation should be addressed to
AIN HOLDINGS INC.
Corporate Planning Division TEL(81)3-5333-1812
https://www.ainj.co.jp/corporate/
This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document has been prepared for information purpose only and does not form part of a solicitation to sell or purchase any securities. Information contained herein may be changed or revised without prior notice. This document may contain forecasting statements as to future results of operations. No forecast statement can be guaranteed and actual results of operations may differ from those projected
© AIN HOLDINGS INC. All Rights Reserved. 6